IRIS
D'ANNA, Rosario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.756
EU - Europa 3.704
AS - Asia 708
OC - Oceania 9
SA - Sud America 3
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.184
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.741
IE - Irlanda 1.026
SE - Svezia 1.007
CN - Cina 617
IT - Italia 562
UA - Ucraina 295
DE - Germania 232
PL - Polonia 175
FI - Finlandia 150
GB - Regno Unito 97
FR - Francia 67
IN - India 55
BE - Belgio 40
RU - Federazione Russa 18
NL - Olanda 17
CA - Canada 15
VN - Vietnam 14
IR - Iran 10
AU - Australia 7
AT - Austria 4
JP - Giappone 4
EC - Ecuador 3
ES - Italia 3
KR - Corea 3
RO - Romania 3
CH - Svizzera 2
IL - Israele 2
LU - Lussemburgo 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
CZ - Repubblica Ceca 1
EG - Egitto 1
EU - Europa 1
HK - Hong Kong 1
KH - Cambogia 1
NG - Nigeria 1
TR - Turchia 1
Totale 8.184
Salva come PNG Salva come JPEG
Città #
Dublin 1.026
Chandler 736
Jacksonville 642
Nyköping 513
Beijing 285
Ashburn 214
Warsaw 174
Princeton 170
Messina 167
Cambridge 157
Medford 153
Dearborn 144
Ann Arbor 139
Des Moines 127
Boardman 79
Jinan 56
Woodbridge 53
Wilmington 44
Shenyang 40
Brussels 37
San Mateo 33
Bremen 30
Catania 30
Hyderabad 28
Lancaster 28
Hebei 26
Zhengzhou 25
New York 23
Los Angeles 22
Ningbo 21
Nanjing 18
Haikou 17
Houston 17
Taizhou 17
Pune 16
Seattle 16
Tianjin 16
Rome 15
Dong Ket 14
Washington 13
Lanzhou 11
Norwalk 11
Guangzhou 10
Nanchang 10
Viagrande 10
Caltagirone 9
Milan 9
Ottawa 9
Hangzhou 8
Ardabil 7
Changsha 7
Falls Church 7
Hefei 7
Trecastagni 7
Auburn Hills 6
Bari 6
Clearwater 6
Jiaxing 5
London 5
Naples 5
Taiyuan 5
Augusta 4
Fuzhou 4
Helsinki 4
Leawood 4
Monmouth Junction 4
Mountain View 4
Turin 4
Bologna 3
Capoterra 3
Florence 3
Kemerovo 3
Mascalucia 3
Modling 3
Mumbai 3
New Delhi 3
Paterno 3
Polverigi 3
Pompei 3
Quito 3
Redmond 3
Rho 3
Riva 3
San Costanzo 3
San Filippo 3
Scandicci 3
Vittoria 3
Waanrode 3
Acireale 2
Amsterdam 2
Andover 2
Boston 2
Brisbane 2
Cagliari 2
Cairo Montenotte 2
Chicago 2
Empoli 2
Greifswald 2
Jeffries 2
Luxembourg 2
Totale 5.653
Salva come PNG Salva come JPEG
Nome #
Inositolo e sindrome metabolica in menopausa 191
Metabolic effects of breastfeeding in women with previous gestational diabetes diagnosed according to the IADPSG criteria 110
Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial 102
Italian risk factor-based screening for gestational diabetes. 91
ADAM 12 and PAPP-A at 14–17 weeks' gestation as biomarkers of pre-eclampsia. 84
Effects of myo-inositol on glucose variability in women with gestational diabetes 84
Antiviral activity of Ellagic acid and Annona Muricata in cervical HPV related pre-neoplastic lesions: A randomized trial 81
Wnt antagonist sclerostin and Dickkopf-1 in gestational diabetes 80
Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study 79
Peroxisome proliferator-activated receptor modulation during metabolic diseases and cancers: master and minions 79
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. 76
Bone remodeling and regulation of sRANKL/OPG balance after genistein administration in osteopenic, postmenopausal women 74
Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: a perspective, randomized, placebo-controlled study. 74
Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial 74
A single abnormal value of the glucose tolerance test is related to increased adverse perinatal outcome. 73
Perinatal outcome in a Caucasian population with gestational diabetes and preexisting diabetes first diagnosed in pregnancy 73
Compliance with hormone replacement therapy in postmenopausal Sicilian women 72
SICUREZZA ED EFFICACIA DELLA GENISTEINA IN DONNE OSTEOPENICHE IN POSTMENOPAUSA 71
Plasma homocysteine in early and late pregnancies complicated with preeclampsia and isolated intrauterine growth restriction 71
First trimester serum PAPP-A and NGAL in the prediction of late-onset pre-eclampsia. 70
Vigilance on use of drugs, herbal products, and food supplements during pregnancy: focus on fosfomycin 69
Decreased endothelial progenitor cells (EPCs) and increased Natural Killer (NK) cells in peripheral blood as possible early markers of preeclampsia: a case-control analysis 68
Coffee intake during pregnancy and neonatal low birth weight: data from a multicenter Italian cross sectional study 68
Antiosteoporotic activity of genistein aglycone in postmenopausal women: Evidence from a post-hoc analysis of a multicenter randomized controlled trial 66
EFFECTS OF THE PHYTOESTROGEN GENISTEIN ON CARDIOVASCULAR RISK FACTORS IN POSTMENOPAUSAL WOMEN. 66
ICAM-1 in maternal serum and amniotic fluid as an early marker of preeclampsia and IUGR 65
Adiponectin and insulin resistance in early- and late-onset pre-eclampsia 65
B cell leukaemia/lymphoma-2 protein concentrations during normal pregnancy 65
Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: A two-year randomized, double-blind, placebo-controlled study 65
Dietary management of skin health: The role of genistein 65
The clinical utility of serum uric acid measurements in pre- eclampsia and transient hypertension in pregnancy 64
Randomized double-blind study evaluating the efficacy on uterine fibroids shrinkage and on intra-operative blood loss of different length of leuprolide acetate depot treatment before myomectomy 64
Myo-inositol and melatonin in the menopausal transition 62
Neutrophil gelatinase-associated lipocalin serum evaluation through normal pregnancy and in pregnancies complicated by preeclampsia. 61
ADAM 12 come marker precoce di preeclampsia 61
GENISTEIN AGLYCONE DOES NOT AFFECT THYROID FUNCTION: RESULTS FROM A THREE-YEAR, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL 61
Plasma adiponectin concentration in early pregnancy and subsequent risk of hypertensive disorders 59
Myo-inositol supplementation reduces the amount of gonadotropins and length of ovarian stimulation in women undergoing IVF: a systematic review and meta-analysis of randomized controlled trials 59
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study 59
Effect of genistein on endothelial function in postmenopausal women: A randomized, double-blind, controlled study 58
First trimester serum neutrophil gelatinase-associated lipocalin in gestational diabetes 58
Peripheral blood CD34+ cells as a novel and noninvasive early marker of first trimester miscarriage: results from a case-control analysis 58
SCLEROSTIN AND DICKKOPF-1 IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 58
Effects of a new vaginal cream containing visnadine, prenylflavonoids and bovine colostrum on Vaginal Health Index Score and Female Sexual Function Index in post-menopausal sexually active women affected by vaginal dryness: A pilot study 58
Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women - A randomized trial 58
Rupture of the cervix in a sulprostone induced abortion in the second trimester 57
Prevalence of risk factors in the screening of carbohydrate intolerance in pregnancy 57
Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and Placebo-controlled Study 57
Cardiovascular effects of the phytoestrogen genistein 57
Dalla soia nuove speranze per la gestione della sindrome metabolica 57
Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: A follow-up study 56
Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study 56
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo controlled study. 56
OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration. 55
The phytoestrogen alpha-zearalenol reverses endothelial dysfunction induced by oophorectomy in rats 55
Positive association between a single abnormal glucose tolerance test value in pregnancy and subsequent abnormal glucose tolerance 55
Genistein aglycone use in metabolic syndrome: preliminary results from a randomized clinical trial in postmenopausal women 55
Results from the International Consensus Conference on myo-inositol and D-chiro-inositol in Obstetrics and Gynecology - assisted reproduction technology 55
The impact of kidney development on the life course: a consensus document for action 55
Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs 55
THE PHYTOESTROGEN GENISTEIN PHYSIOLOGICALLY IMPROVES BONE AND CARDIOVASCULAR FUNCTIONALITY IN POSTMENOPAUSAL WOMEN 54
Myo-inositol may prevent gestational diabetes in PCOS women 54
Large placental chorioangioma 53
Midtrimester amniotic fluid adiponectin in normal pregnancy. 53
Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor kappa B ligand-osteoprotegerin system in early postmenopausal women 53
Myo-inositol supplementation to prevent gestational diabetes in overweight non-obese women: bioelectrical impedance analysis, metabolic aspects, obstetric and neonatal outcomes–a randomized and open-label, placebo-controlled clinical trial 53
Association of maternal food insecurity before and during pregnancy with fetal structural anomalies: A multicenter case-control study protocol 53
Neurokinin B peptide levels in normal pregnancy 52
C-reactive protein as an early predictor of gestational diabetes mellitus 52
Cardiovascular effects of raloxifene hydrochloride 52
Positive effects of the phytoestrogen genistein on bone metabolism in postmenopausal women 51
Urinary excretion of aquaporin-2 water channel during pregnancy 51
GENISTEIN AGLYCONE: A DUAL MODE OF ACTION ANTI-OSTEOPOROTIC SOY ISOFLAVONE REBALANCING BONE TURNOVER TOWARDS BONE FORMATION 51
Effects of prepregnancy body mass index and weight gain during pregnancy on perinatal outcome in glucose-tolerant women. 51
Vitamin D in human reproduction: the more, the better? An evidence-based critical appraisal 51
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women 50
Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: a randomized, double-blind, placebo-controlled study 50
Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia. 50
La disfunzione diastolica nel diabete gestazionale 50
Concentration of circulating endothelial progenitor cells (EPC) in normal pregnancy and in pregnant women with diabetes and hypertension 50
Genistein effects on quantitative ultrasound parameters and bone mineral density in osteopenic postmenopausal women 50
Is mid-trimester maternal serum inhibin-A a marker of preeclampsia or intrauterine growth restriction? 49
Myo-inositol supplementation and the onset of gestational diabetes mellitus in pregnant women with a family hystory of type 2 diabetes. A prospective, randomized, placebo controlled study 49
Midtrimester Amniotic Fluid Leptin and Insulin Levels and Subsequent Gestational Diabetes. 48
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study 48
First- and Second-Trimester ADAM12s in Down Syndrome Screening. 48
Effetti del fitoestrogeno genisteina su donne in post-menopausa affette da sindrome metabolica 48
Maternal serum PAPP-A as an early marker of obstetric complications? 48
A New Supplement for the Treatment of Metabolic Syndrome in Postmenopausal Women 48
PREGNANCY IN THE OBESE PATIENT 47
Livelli serici di OPG e RANKL in donne osteopeniche in post-menopausa, trattate per 2 anni col fitoestrogeno genisteina 47
Differenze socio.demografiche e psicologiche tra gruppi di pazienti in peri e post menopausa 47
Myo-Inositol for the Prevention of Gestational Diabetes Mellitus. A Brief Review 47
Neurokinin B and nitric oxide plasma levels in pre-eclampsia and isolated intrauterine growth restriction 46
Positive effects of the isoflavone genistein on cardiovascular system in osteopenic, postmenopausal women 46
Endothelin-1 production in umbilical arteries from hypertensive pregnant women 46
Valutazione ecocardiografica in pazienti affette da diabete mellito gestazionale: Dati preliminari 46
Abnormal glucose tolerance later in life in women affected by glucose intolerance during pregnancy 46
Effects of the Phytoestrogen Genistein on Bone Metabolism in Osteopenic, Postmenopausal Women: A Randomized Trial 45
Effects of genistein aglycone on endometrial hyperplasia in premenopausal women: a randomized controlled trial 45
Totale 6.085
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.976
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.976
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201917 0 0 0 0 0 0 0 0 0 0 8 9
2019/20201.331 179 77 16 62 13 140 174 134 51 234 212 39
2020/20211.266 127 30 263 73 91 120 90 128 73 138 79 54
2021/20221.216 11 145 29 44 47 15 70 44 35 282 148 346
2022/20233.036 223 283 149 185 252 300 33 177 1.289 16 96 33
2023/2024606 60 108 43 106 62 111 27 30 0 58 1 0
Totale 8.436